Jim Stack
InvesTech Market Analyst
Andy Obermueller
Fast-Track Millionaire
Mike Cintolo
Cabot Top Ten Trader
Elliott Gue
Personal Finance

Top picks 2012: Ford


Bookmark and Share
by Nicholas Vardy, editor Bull Market Alert

Nicholas VardyOur top pick is all-American stalwart and success story Ford Motor Co. (F) -- a bet on the American consumer and the burgeoning U.S. economic recovery.

Even as Europe struggles with its sovereign debt crisis, the news from the U.S. economy has been steadily improving.

The Institute for Supply Management reported that the U.S. manufacturing index rose to 52.7 in November, and that new orders and production both rose to seven-month highs.

The unemployment rate recently dropped down to 8.6%. Consumer confidence has ticked up and U.S consumers went on an auto spending spree in November -- a normally weak month for auto sales.

With the average age of vehicles on U.S. roads hitting almost 11 years, pent-up demand resulted in an impressive 10.6% rise in seasonally adjusted annual sales (SAAS) to 13.6 million units as of last month.
Advertisement
Banner


That's up from a SAAS total of 12.28 million in the same month of 2010 and the highest SAAS rate since August 2009, when the U.S. government launched the “Cash for Clunkers” program. November was also the third-straight month when annualized vehicle sales have topped the 13-million mark.

Ford itself posted double-digit gains of 13.3% in November to 166,865 vehicles, driven by strong sales of trucks and SUVs. Its 16.6% share of U.S. vehicle sales in November was its highest level in five years.

Ford's retail sales actually soared by an even more impressive 20%. Retail sales, as opposed to sales to fleets like rental-car companies and government agencies, rank as the industry's most profitable segment.

Ford itself expects an industry-wide sales rate of around 13.5 million units for all of next year.

Ford also announced that it would restore a regular dividend. Ford halted its dividend payment back in 2006 when markets were in turmoil. Restoration of a dividend payment is a good sign of financial strength.

Much of Ford's success has been thanks to its CEO Alan Mulally, who has prioritized profits over market share.

Coming to Ford from Boeing just five years ago in September 2006, Mulally eliminated Ford's dividend and sold Ford's non-core brands. He also shut down Mercury, focusing Ford on the mass market and Lincoln on the high-end car buyers.

He also raised $20 billion as a cushion against bad times that has served Ford well, while delivering nine straight quarters of pre-tax profits.

Ford was a darling of investors after the market bottomed in March 2009 but has actually underperformed the broader market since hitting a high of $18.71 in January of this year.

But with a price-to-earnings ratio (P/E) of 6.56, and a turnaround in the U.S. car market underway, Ford is once again a bargain. So, bet on a U.S. economic turnaround and buy Ford Motor Co.

Learn more about this financial newsletter at Nicholas Vardy's Bull Market Alert.

News Flash

Asia tech turnarounds: TSM and LPL
by Yiannis Mostrous, editor Passport to Profits.

Taiwan Semiconductor (TSM) is undervalued and offers solid growth prospects. And South Korea's LG Display (LPL) is a turnaround technology story.


Read more...

 

NASDAQ OMX: Contrarian buy
by Christian DeHaemer, editor Wealth Daily

Remember the NASDAQ? You may not have noticed, but it's up 133% since the bottom in 2009.


Read more...


   

Zoll: Small cap manager eyes LifeVest
by Benjamin Shepherd, editor ETF Investment Insider

I recently spoke with Ken Salmon, co-manager of BMO Small-Cap Growth (MRSCX), who explained his investment process and shared his market outlook. Below, he highlights his reasons for owning Zoll Medical (ZOLL).


Read more...

 

Contarian plays on housing
by Steve Mauzy, contributing editor Daily Profit

As a contrarian, I'm interested in housing, as pessimism always creates opportunities. And the time to invest is when the market is near a bottom, which I believe is the case today.


Read more...

 

Pile's top picks in biotech
by Nate Pile, editor Nate's Notes

The biotech sector has been on fire in recent months, and I consider Cubist (CBST) and Gen-Probe (GPRO) as top picks. Their chart patterns have “bullish” written all over them.


Read more...

 

A 'Stellar' play: Netease
by Richard Schmidt, editor Stellar Stock Alert

It appears that we finally have a bottom in place for the ishares FTSE/Xinhua China ETF (FXI). Among our individual stock recommendations, Netease (NTES) appears ready for a long extended rally.


Read more...

 

Cameco gets boost from China
by Gordon Pape, editor Internet Wealth Builder

It's been a rough time for Cameco Corp. (CCJ), the world's number one uranium producer. The stock fell as low as C$17.25 in late November, a level it hadn't seen since the crash of 2008-09.


Read more...

 

February warning?
by Sy Harding, editor Street Smart Report

One seasonal pattern to consider is the tendency for the market to run into trouble in February. Indeed, Februaries have been particularly troublesome since 1999, falling in 8 of those 13 years, with an average decline of 4.3% in the down years.


Read more...

 

Central Gold: The one to 'Trust'
by Curtis Hesler, editor Professional Timing Service

In the near term, it is not surprising to see gold encounter some selling at the $1,750 - $1,800 level, and a brief spate of profit taking is in order. 


Read more...

 

Low-Priced: Tillinghast returns
by Jim Lowell, editor Fidelity Investor

I recently talked with Joel Tillinghast and welcomed him back after taking some time off as manager for Fidelity Low-Priced Stock (FLPSX).


Read more...